Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F6V3R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,458
Award facts
- Contract value 100% obligated
- $4,458.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,458.20 to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 mL pen injections on December 22, 2025, with completion expected by December 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, supplies critical medical commodities to federal healthcare systems through its extensive contract portfolio with the Defense Logistics Agency. The company's federal procurement activities encompass a broad range of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies supporting multiple therapeutic domains. This Zepbound delivery order fulfills federal medical supply requirements for the military healthcare system, enabling the Defense Health Agency and other government healthcare entities to access FDA-approved diabetes and weight management medications through AmerisourceBergen's established distribution network.
Quick answers
Who was awarded contract SPE2DR26F6V3R?
SPE2DR26F6V3R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26F6V3R worth?
The government has obligated $4,458 on SPE2DR26F6V3R.
Is contract SPE2DR26F6V3R an order under another contract?
Yes. SPE2DR26F6V3R is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6V3R competed?
The extent of competition for SPE2DR26F6V3R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award